Report Categories
View AllRecent Articles
View All
SNEX StoneX Group Inc notches wider than expected Q1 2026 earnings beat shares edge higher after results
CLDI Calidi Biotherapeutics Inc posts 736 positive Q4 2025 EPS surprise shares edge slightly lower in todays trading
MIDD Middleby Corporation The reports Q4 2025 earnings beat with mild year over year revenue and share price growth
FGSN F and G Annuities and Life Inc posts 266 percent Q4 2025 EPS miss shares dip 033 percent today
Tailwind TDWDR Stalls at 012 Consolidation Phase 20260519
Indonesia Accelerates WastetoEnergy Plans to Enhance Energy SelfSufficiency
First FIBK Stock Analysis 088 Gain What to Watch 20260518
Jaguar Health JAGX Q3 2025 Earnings Miss by Significant Key Takeaways
Floridas Tax Haven Appeal Fades as Exodus Trend Gains Momentum
Analyst Favorites Highlight Earnings Growth Potential in Seven Stocks Solar Stock Breaks Key Level
Jim Cramer Analyzes NVIDIAs Latest Quarterly Performance Key Insights for Investors
Burberry Shares Surge on Report of Potential Moncler Takeover Bid
US Consumer Prices Rise 38 Annually in April Exceeding Expectations
Venture Capital Targets Boring Businesses with Thin Margins Using AI and Deal Flow
BSET Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Furniture Market
Skye Bioscience Inc SKYE Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Surges on Pipeline Progress
BHFAP Q1 2026 Earnings EPS Misses Estimates Preferred Stock Declines
Avino Silver Gold Mines Ltd ASM Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency
MNKD Q1 2026 Earnings Significant EPS Miss Overshadowed by Stock Rally
Organigram Global Inc OGI Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively
Energy Services of America ESOA Declines 55 Amid ProfitTaking and Sector Weakness
Krispy Kreme Holds Steady at 337 as Support and Resistance Levels Come into Focus
Core AI Holdings CHAI Declines 089 Holds Above Key Support at 105
Herc Holdings HRI Slips Slightly Support and Resistance Levels in Focus
Alnylam Pharmaceuticals ALNY Holds Near Support Amid Modest Decline